BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32384577)

  • 1. Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome.
    Higuchi S; Kabeya Y; Nishina Y; Miura Y; Yoshino H
    Catheter Cardiovasc Interv; 2020 Dec; 96(7):E666-E673. PubMed ID: 32384577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of noncontrast percutaneous coronary intervention in patients with acute coronary syndrome.
    Higuchi S; Kabeya Y; Nishina Y; Miura Y; Shibata S; Hata N; Suda T; Hirabuki K; Hasegawa H; Yoshino H; Matsuda T
    J Med Invest; 2022; 69(1.2):57-64. PubMed ID: 35466147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention.
    Murat SN; Kurtul A; Yarlioglues M
    Angiology; 2015 Sep; 66(8):732-7. PubMed ID: 25260710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
    Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of concomitant peripheral artery disease on contrast-induced acute kidney injury and mortality in patients with acute coronary syndrome after percutaneous coronary intervention.
    Nakahashi T; Tada H; Sakata K; Yakuta Y; Yoshida T; Tanaka Y; Nomura A; Terai H; Horita Y; Ikeda M; Namura M; Takamura M; Kawashiri MA
    Heart Vessels; 2020 Oct; 35(10):1360-1367. PubMed ID: 32342211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T
    Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Lima FV; Singh S; Parikh PB; Gruberg L
    Cardiovasc Revasc Med; 2018 Sep; 19(6S):16-20. PubMed ID: 29929842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
    Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and Incidence of Contrast-Induced Acute Kidney Injury Following Coronary Angiography - Five Year Experience at a Tertiary Care Center.
    Sreenivasan J; Khan MS; Li H; Zhuo M; Patel A; Fugar S; Tarbutton M; Siddamsetti S; Yadav N
    Cardiovasc Revasc Med; 2019 Aug; 20(8):654-658. PubMed ID: 30318173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry.
    Valle JA; McCoy LA; Maddox TM; Rumsfeld JS; Ho PM; Casserly IP; Nallamothu BK; Roe MT; Tsai TT; Messenger JC
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome.
    Celik IE; Kurtul A; Duran M; Yarlioglues M; Elcik D; Kilic A; Koseoglu C; Oksuz F; Murat SN
    Coron Artery Dis; 2016 Jan; 27(1):13-8. PubMed ID: 26267748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Contrast Media Volume-Glomerular Filtration Rate Ratio and Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Intervention.
    Celik O; Ozturk D; Akin F; Ayca B; Yalcın AA; Erturk M; Bıyık I; Ayaz A; Akturk IF; Enhos A; Aslan S
    Angiology; 2015 Jul; 66(6):519-24. PubMed ID: 25005762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.
    Watabe H; Sato A; Hoshi T; Takeyasu N; Abe D; Akiyama D; Kakefuda Y; Nishina H; Noguchi Y; Aonuma K
    Int J Cardiol; 2014 Jun; 174(1):57-63. PubMed ID: 24726211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention.
    Ohno Y; Maekawa Y; Miyata H; Inoue S; Ishikawa S; Sueyoshi K; Noma S; Kawamura A; Kohsaka S; Fukuda K
    J Am Coll Cardiol; 2013 Oct; 62(14):1260-1266. PubMed ID: 23770181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
    Zahler D; Rozenfeld KL; Merdler I; Peri Y; Shacham Y
    Cardiorenal Med; 2020; 10(2):108-115. PubMed ID: 31801134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, Predictors, and Impact on Six-Month Mortality of Three Different Definitions of Contrast-Induced Acute Kidney Injury After Coronary Angiography.
    Guillon B; Ecarnot F; Marcucci C; Ducloux D; Chatot M; Badoz M; Bonnet B; Chopard R; Frey P; Meneveau N; Schiele F
    Am J Cardiol; 2018 Apr; 121(7):818-824. PubMed ID: 29397881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.
    Xu ZR; Chen J; Liu YH; Liu Y; Tan N
    BMC Cardiovasc Disord; 2019 Feb; 19(1):36. PubMed ID: 30744553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
    Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.